Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Event Type
Facet Toggle
Time Frame
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 25, 2025
Reducing access to vital treatments against drug-resistant TB will likely pose huge risks for everyone, including Americans. The 90-day freeze on most aid while this assessment is carried out causes real challenges for accessing medication. Even though waivers have been written for TB treatment and ...
WORKING PAPER
January 29, 2025
This study estimates the costs of four key interventions to mitigate antimicrobial resistance globally by 2050. These interventions include improving access to water, sanitation, and hygiene, enhancing childhood vaccination, developing new antibiotics, and increasing access to healthcare and existin...
WORKING PAPER
January 29, 2025
This study estimates the global inpatient healthcare costs attributable to antimicrobial resistance (AMR) and projects future expenditures across different scenarios. It finds that AMR accounts for 25.4 million hospital admissions annually, resulting in $66.4 billion in excess healthcare costs, with...
WORKING PAPER
January 29, 2025
Antimicrobial resistance (AMR) poses a major global challenge, affecting both human health and economies. This research models the potential impacts of AMR on global GDP and various sectors, showing that while better treatment and combined interventions can boost economic growth, accelerated resista...
Working Groups
December 18, 2024
CGD is forming a working group to create an Advance Market Commitment (AMC) for rapid neonatal sepsis tests in low- and middle-income countries (LMICs), with funders pledging top-up payments to incentivize private companies to develop and supply these critical diagnostics.
Blog Post
October 07, 2024
One of the main drivers of the problem of antimicrobial resistance (AMR)—an impending crisis which already causes over 1.25 million annual deaths globally and nearly 300,000 annual deaths in India—is the overuse of antibiotics. While access to antibiotics is key to prevent mortality, insufficient co...
BRIEF
September 30, 2024
Antimicrobial resistance (AMR) is responsible for a large and growing burden of mortality, morbidity, and economic impacts. This is due to three underlying problems: lack of access to essential antimicrobials, insufficient stewardship of these drugs to prevent overuse and misuse, and a dearth of inn...
